One-Pot Synthesis of Fe-Norepinephrine Nanoparticles for Synergetic Thermal-Enhanced Chemodynamic Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39392201.
- Also identified by DOI 10.1021/acs.nanolett.4c04375.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chemodynamic therapy (CDT) is an innovative and burgeoning strategy that utilizes Fenton-Fenton-like chemistry and specific microenvironments to produce highly toxic hydroxyl radicals (<sup>•</sup>OH), with numerous methods emerging to refine this approach. Herein, we report a coordination compound, Fe-norepinephrine nanoparticles (Fe-NE NPs), via a one-pot synthesis. The Fe-NE NPs are based on ferrous ions (Fe<sup>2+</sup>) and norepinephrine, which are capable of efficient Fe<sup>2+</sup>/Fe<sup>3+</sup> delivery. Once internalized by tumor cells, the released Fe<sup>2+</sup>/Fe<sup>3+</sup> exerts the Fenton reaction to specifically produce toxic <sup>•</sup>OH. Moreover, the internal photothermal conversion ability of Fe-NE NPs allows us to simultaneously introduce light to trigger local heat generation and then largely improve the Fenton reaction efficiency, which enables a synergetic photothermal and chemodynamic therapy to realize satisfactory <i>in vivo</i> antitumor efficiency. This proof-of-concept work offers a promising approach to developing nanomaterials and refining strategies for enhanced CDT against tumors.
Medical subject headings
- Norepinephrine